Verrica Pharmaceuticals (VRCA) Operating Leases (2019 - 2026)
Verrica Pharmaceuticals' Operating Leases came in at $61,000 for Q2 2026, down 85.3% from $416,000 a year earlier and down 59.9% from the prior quarter.
Powered by 
Analysis
Verrica Pharmaceuticals (VRCA) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Verrica Pharmaceuticals' Operating Leases was $242,000, down 58.5% from FY2024.
- Operating Leases has declined in each of the last five years, with a five-year compound annual growth rate of -32.2% (FY2020 to FY2025).
- Going back by year, Operating Leases was $583,000 in FY2024 (-35.9%), $910,000 in FY2023 (-26.0%), $1.23 million in FY2022 (-15.2%) and $1.45 million in FY2021 (-14.4%).
- The Q2 2026 figure represents the lowest quarterly Operating Leases since Q1 2020.
- Year-over-year, Operating Leases has declined for 20 consecutive quarters, with an average decline of 52.0% over the last eight quarters.
- The year-over-year decline in Operating Leases has ranged between 12.3% (Q2 2022) and 85.3% (Q2 2026) over the last five years.
- Business Quant data shows VRCA's Operating Leases at $152,000 (Q1 2026), $242,000 (Q4 2025) and $330,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Verrica Pharmaceuticals | 79.02 Mn | -4.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61,000.00 |
| Mar 31, 2026 | 152,000.00 |
| Dec 31, 2025 | 242,000.00 |
| Sep 30, 2025 | 330,000.00 |
| Jun 30, 2025 | 416,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 583,000.00 |
| Sep 30, 2024 | 665,000.00 |
| Jun 30, 2024 | 744,000.00 |
| Mar 31, 2024 | 825,000.00 |
| Dec 31, 2023 | 910,000.00 |
| Sep 30, 2023 | 989,000.00 |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 1.51 Mn |
API Access
Verrica Pharmaceuticals Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=VRCA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "VRCA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=VRCA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();